A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma

A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma

Background: Multiple myeloma bone disease (MMBD) constitutes a common and severe complication of multiple myeloma (MM), impacting the quality of life and survival. We evaluated the clinical value of a panel of 19 miRNAs associated with osteoporosis in MMBD. Methods: miRNAs were isolated from the pla...

Full description

Bibliographic Details
Main Authors: Aristea-Maria Papanota, Panagiotis Tsiakanikas, Christos K. Kontos, Panagiotis Malandrakis, Christine-Ivy Liacos, Ioannis Ntanasis-Stathopoulos, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Margaritis Avgeris, Meletios-Athanasios Dimopoulos, Andreas Scorilas, Evangelos Terpos
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cancers
Subjects:
blood plasma
circulating miRNA
molecular biomarker
hematological malignancies
MMBD diagnosis
osteolysis
Online Access:https://www.mdpi.com/2072-6694/13/15/3877

Internet

https://www.mdpi.com/2072-6694/13/15/3877

Similar Items